KLK3 and neoplasm: Despite identifying several molecular mechanisms associated with radioresistance, the ability to predict an individual PCa patient’s response to RT is still limited and based mostly on the pretreatment assessment of prostate specific antigen (PSA), tumor stage and Gleason score [3,4].